BioSpace News Archive

Today, Abbott (NYSE: ABT) and the American Diabetes Association® (ADA) announced that Abbott has become the first anchor sponsor of the Health Equity Now (HEN) platform to address health disparities for people with diabetes

Healint , a leading provider of healthcare technology and developer of the Migraine Buddy tracking app, is now recruiting patients for its third virtual global clinical trial

Tel Aviv University and The Sagol Center for Hyperbaric Medicine and Research at Shamir Medical Center announced today that, for the first time in humans, two key biological hallmarks of aging, telomere length shortening and accumulation of senescent cells, can be reversed, according to a new study.

The Phase number of the clinical trial in the first paragraph, first sentence of release should read: Phase I/II (instead of Phase I/I). The updated release reads: ORGANICELL ANNOUNCES ADDITIONAL SITE FOR PHASE I/II CLINICAL TRIAL OF ZOFIN™ FOR TREATMENT OF COVID-19

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) is pleased to announce that the company has closed a $50 million Licensing and Development Agreement with a consortium of partners in China for the Ii-Key vaccine platform technology from Generex subsidiary NuGenerex Immuno-Oncology (NGIO)

Obsidian Therapeutics, Inc. and The University of Texas MD Anderson Cancer Center today announced a multi-year strategic collaboration designed to expedite the research and development of novel engineered tumor infiltrating lymphocytes (TILs) for the treatment of solid tumors.

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the commercial launch of Cohere® XLIF®, the first Porous PEEK™ interbody brought to market for use in eXtreme Lateral Interbody Fusion (XLIF) and X360™ surgeries.

CreaGen Inc., a 17-year-old medicinal chemistry and drug discovery research service provider, has been awarded a 7-year Indefinite-Delivery/Indefinite Quantity (IDIQ) type base contract by NIAID to provide preclinical services for HIV therapeutics, marking the company’s first multi-year federal partnership.

ValGenesis, Inc., a market leader in Enterprise Validation Lifecycle Management Systems, announced that a global Top 5 life science organization has chosen ValGenesis VLMS to digitize and standardize validation processes across its global sites.

Global Industrial , a value-added national distributor of industrial products and MRO supplies, a Systemax Inc. (NYSE:SYX) company, today announced the publication of its Ready. Set. Vaccinate; guide to help healthcare facilities, pharmacies, doctors offices and more, be prepared to administer COVID-19 vaccines